Medical Xpress September 11, 2024
You don’t often see a “science day” in a Philadelphia courtroom. But that’s exactly what happened last week in a potentially ground-shifting legal fight brought by patients against the manufacturers of blockbuster drugs for diabetes and weight loss.
At the heart of the case are the drugs in question: Ozempic, Wegovy, and others that work in a similar way. The drugs—which help regulate blood sugar levels and reduce body weight—have been hailed as a “miracle,” and have become a hot commodity, used by one in eight U.S. adults, according to a recent poll.
Now, some patients are suing Novo Nordisk and Eli Lilly, the manufacturers of the medications, claiming they were not adequately warned of the potentially serious side effects...
Today's Sponsors
Today's Sponsor